John W Holaday

Dr. John Holaday is the Managing Director, CEO, Chief Scientific Officer and founding Director of QRxPharma (QRX, ASX). Previously, he served as co-founder of EntreMed, Inc. (ENMD, NASDAQ) in 1992, Medicis Pharmaceutical Corp. (MRX, NYSE) in 1988. He also founded MaxCyte, Inc. and is a member of the Board of Directors of Neuren (ASX), Pixspan, Plasmonix, CytImmune Sciences and Accelovance. He has raised over $500MM in private and public rounds of financing for these companies that have a collective market capitalization in excess of $2 billion. Dr. Holaday served as a Captain in the US Army, and was at the Walter Reed Army Institute of Research as an officer and civilian for 21 years. Dr. Holaday obtained his BS (1966) and MS (1968) from the University of Alabama (UofA), and his PhD from the University of California, San Francisco in 1976. He was Professor of Anesthesiology and Critical Care Medicine at the Johns Hopkins University School of Medicine (until 1996) and is Professor of Psychiatry at the Uniformed Services University of the Health Sciences. He is former Chair of the BioAlliance of the Tech Council of Maryland. Dr. Holaday serves on the Leadership Board for the College of Arts and Sciences, UofA, formerly with the Leadership Board of the University of Maryland Biotechnology Institute, and the Judges Panel for the Ernst and Young Entrepreneur of the Year (2003-2007). Dr. Holaday was awarded the Algernon Sydney Sullivan Outstanding Alumnus Award by the University of Alabama (2008), and was named to the Ernst&Young’s Entrepreneur of the Year 2006 Hall of Fame. Dr. Holaday holds over 65 patents and published over 230 scientific articles, book chapters and four books.